The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 Quilt 88 trial of DAMP inducers combined with IL15 superagonist, N-803, and anti–PD-L1 NK cell therapy more than doubles historical overall survival in patients with third- to sixth-line advanced pancreatic cancer.
 
Tara Elisabeth Seery
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer; Ipsen
 
Chaitali Singh Nangia
Consulting or Advisory Role - Novartis
Speakers' Bureau - Merck; Novartis
Travel, Accommodations, Expenses - Novartis
 
Heidi Ann McKean
No Relationships to Disclose
 
Paul Bhar
Employment - ImmunityBio
Stock and Other Ownership Interests - ImmunityBio
 
Leonard S. Sender
Employment - ImmunityBio
Leadership - ImmunityBio
Stock and Other Ownership Interests - ImmunityBio
Consulting or Advisory Role - Anthem Blue Cross Blue Shield
 
Sandeep K. Reddy
Employment - ImmunityBio
Stock and Other Ownership Interests - ImmunityBio; NantHealth
 
Patrick Soon-Shiong
Employment - ImmunityBio; NantHealth; NantWorks
Leadership - ImmunityBio; NantHealth; NantWorks
Stock and Other Ownership Interests - ImmunityBio; NantHealth; NantWorks
Patents, Royalties, Other Intellectual Property - NantWorks & Affiliates, NantKwest, ImmunityBio